Long Term Follow-up of Patients with Adrenal Incidentalomas- A Single Center Experience and Review of the Literature

Abstract

Introduction: Adrenal incidentalomas (AIs) constitute an emerging clinical entity due to the increased use of abdominal imaging for diagnostic purposes. Most often it consists of benign-nonfunctioning lesions and an increase in size during follow-up is reported in about 9% (0–26%), whereas their functional evolution is rare.

Materials and methods: Sixty-four patients (22 males and 42 females; mean age 61.6±1.2 years), with AIs and follow-up of 3.1±0.4 years (range 0–19) were retrospectively evaluated. The patients underwent basal and dynamic evaluation of the hypothalamic-pituitary-adrenal axis, renin-angiotensin-aldosterone system and adrenomedullary function. Mass enlargement and adrenal hyperfunction were estimated at yearly intervals.

Results: Adrenalectomy was performed in 5 patients (4 benign cortical adenomas and 1 pheochromocytoma). Abnormal manifestation, based on clinical, laboratory and histological evaluation, was observed in 4 patients [1 (1.56%) with SCS, 2 (3.12%) with pheochromocytoma and 1 (1.56%) with aldosteronoma], 3 of which were diagnosed at their initial evaluation and 1 at the 3^rd year of follow-up. The remainders [60 patients (93.75%)] were harbouring a non-secretory mass (8 potential myelolipomas, 8 nodular hyperplasias, 3 cystic lesions). Eleven patients (17.2%) had bilateral AIs. Mass enlargement (5–13 mm) was observed in 9 patients (14%), ≥10 mm 4 (6.25%), while mass shrinkage (5–19 mm) in 3 (4.7%) during follow-up. No hormonal evolution was noticed.

Conclusions: AIs present usually as benign, non-secretory lesions. Criteria for surgical intervention were met at initial assessment for the majority of AIs. Size alterations during follow-up are uncommon and functional evolution is rare.

adrenal mass - adrenalectomy - aldosteronoma - Cushing's syndrome - incidentaloma - pheochromocytoma

References

• 1 Abecassis M, McLoughlin MJ, Langer B. et al . Serendipitous adrenal masses: prevalence, significance, and management.  Am J Surg. 1985;  149 783-788
• 2 Anagnostis P, Karagiannis A, Tziomalos K. et al . Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens). 2009;  8 163-184
• 3 Barry MK, van Heerden JA, Farley DR. et al . Can adrenal incidentalomas be safely observed?.  World J Surg. 1998;  22 599-603
• 4 Barzon L, Scaroni C, Sonino N. et al . Risk factors and long-term follow-up of adrenal incidentalomas.  J Clin Endocrinol Metab. 1999;  84 520-526
• 5 Barzon L, Fallo F, Sonino N. et al . Development of overt Cushing's syndrome in patients with adrenal incidentaloma.  Eur J Endocrinol. 2002;  146 61-66
• 6 Barzon L, Sonino N, Fallo F. et al . Prevalence and natural history of adrenal incidentalomas.  Eur J Endocrinol. 2003;  149 273-285
• 7 Bastounis EA, Karayiannakis AJ, Anapliotou ML. et al . Incidentalomas of the adrenal gland: diagnostic and therapeutic implications.  Am Surg. 1997;  63 356-360
• 8 Bencsik Z, Szabolcs I, Góth M. et al . Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach.  J Intern Med. 1995;  237 585-589
• 9 Bornstein SR, Stratakis CA, Chrousos GP. Adrenocortical tumors: recent advances in basic concepts and clinical management.  Ann Intern Med. 1999;  130 759-771
• 10 Bülow B, Jansson S, Juhlin C. et al . Adrenal incidentaloma – follow-up results from a Swedish prospective study.  Eur J Endocrinol. 2006;  154 419-423
• 11 Caplan RH, Strutt PJ, Wickus GG. Subclinical hormone secretion by incidentally discovered adrenal masses.  Arch Surg. 1994;  129 291-296
• 12 Cerfolio RJ, Vaughan ED, Brennan TG. et al . Accuracy of computed tomography in predicting adrenal tumor size.  Surgery. 1993;  176 307-309
• 13 Dobbie JW. Adrenocortical nodular hyperplasia: the ageing adrenal.  J Pathol. 1969;  99 1-18
• 14 Funder JW, Carey RM, Fardella C. et al . Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab. 2008;  93 3266-3281
• 15 Gopan T, Remer E, Hamrahian AH. Evaluating and managing adrenal incidentalomas.  Cleve Clin J Med. 2006;  73 561-568
• 16 Grossrubatscher E, Vignati F, Possa M. et al . The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.  J Endocrinol Invest. 2001;  24 846-855
• 17 Grundy SM, Cleeman JI, Merz CN. et al . Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.  Circulation. 2004;  110 227-239
• 18 Grumbach MM, Biller BM, Braunstein GD. et al . Management of the clinically inapperent adrenal mass (“incidentaloma”).  Ann Intern Med. 2003;  138 424-429
• 19 Hamrahian AH, Ioachimescu AG, Remer EM. et al . Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience.  J Clin Endocrinol Metab. 2005;  90 871-877
• 20 Herrera MF, Grant CS, van Heerden JA. et al . Incidentally discovered adrenal tumors: an institutional perspective.  Surgery. 1991;  110 1014-1021
• 21 Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J. et al . 1 111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors.  Ann N Y Acad Sci. 2006;  1073 38-46
• 22 Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors.  J Clin Endocrinol Metab. 1997;  82 1317-1324
• 23 Libè R, Dall’Asta C, Barbetta L. et al . Long-term follow-up study of patients with adrenal incidentalomas.  Eur J Endocrinol. 2002;  147 489-494
• 24 Luton JP, Martinez M, Coste J. et al . Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center.  Eur J Endocrinol. 2000;  143 111-117
• 25 Manassero F, Pomara G, Rappa F. et al . Adrenal myelolipoma associated with adenoma.  Int J Urol. 2004;  11 326-328
• 26 Mansmann G, Lau J, Balk E. et al . The clinically inapparent adrenal mass: update in diagnosis and management.  Endocr Rev. 2004;  25 309-340
• 27 Mantero F, Terzolo M, Arnaldi G. et al . A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.  J Clin Endocrinol Metab. 2000;  85 637-644
• 28 Maurea S, Klain M, Mainolfi C. et al . The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.  J Nucl Med. 2001;  42 884-892
• 29 Mayo-Smith WW, Boland GW, Noto RB. et al . State-of-the-art adrenal imaging.  Radiographics. 2001;  21 995-1012
• 30 Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment.  J Urol. 2003;  169 5-11
• 31 Nieman LK, Biller BM, Findling JW. et al . The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab. 2008;  93 1526-1540
• 32 Rossi R, Tauchmanova L, Luciano A. et al . Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.  J Clin Endocrinol Metab. 2000;  85 1440-1448
• 33 Sirén J, Tervahartiala P, Sivula A. et al . Natural course of adrenal incidentalomas: seven-year follow-up study.  World J Surg. 2000;  24 579-582
• 34 Tamidari H, Mishra AK, Gupta S. et al . Catecholamine secreting adrenal myelolipoma.  Indian J Med Sci. 2006;  60 331-333
• 35 Terzolo M, Ali A, Osella G. et al . Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici.  Arch Surg. 1997;  132 914-919
• 36 Terzolo M, Osella G, Alì A. et al . Subclinical Cushing's syndrome in adrenal incidentaloma.  Clin Endocrinol (Oxf). 1998;  48 89-97
• 37 Tsvetov G, Shimon I, Benbassat C. Adrenal incidentaloma: clinical characteristics and comparison between patients with and without extraadrenal malignancy.  J Endocrinol Invest. 2007;  30 647-652
• 38 Virkkala A, Välimäki M, Pelkonen R. et al . Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography.  Acta Endocrinol (Copenh). 1989;  121 67-72
• 39 Young WF. Primary aldosteronism: renaissance of a syndrome.  Clin Endocrinol (Oxf). 2007;  66 607-618
• 40 Young Jr WF. Clinical practice. The incidentally discovered adrenal mass.  N Engl J Med. 2007;  356 601-610

Correspondence